Carol Hamilton, PharmD
Dr. Carol Hamilton received a Bachelor of Science degree in Psychology from the University of Florida in 1989 then received a Doctor of Pharmacy degree in 1994. She then completed a post-doctoral fellowship in infectious disease. Dr. Hamilton worked as the Director of Training and Education for a pharmacy-based company and traveled to hospitals around the country training pharmacists and other hospital staff on the implementation of antibiotic management programs and tracking systems for antimicrobial resistance in their institutions. Personally, she experienced a sudden onset of severe preeclampsia in her first pregnancy, which resulted in the loss of her daughter. Midway through her second pregnancy Dr. Hamilton stepped down from her pharmacy position and is now a full-time mother to Lexie and Zachary. She and her husband live in Naples, Florida. She has served as a Board Director since 2004.

K. Kimberly McCleary
As President and CEO, Kimberly McCleary has – for 15 years – led the CFIDS Association of America’s education, public policy and research programs which seek to bring an end to chronic fatigue and immune dysfunction syndrome and the suffering it causes. She has worked closely with the Centers for Disease Control and Prevention (CDC), the National Institutes of Health (NIH) and Congress to define priorities and provide funding for CFS research. Ms. McCleary has developed and managed CDC-sponsored activities to educate health care professionals and the public about CFS, including developing the first national public awareness campaign for CFS. She also worked closely with the Social Security Administration to develop a policy ruling identifying CFS as a potentially disabling condition, making it easier for disabled CFS patients to gain access to federal disability benefits. She served on the Department of Health and Human Services CFS Coordinating Committee from 1996 until 2001, has testified before Congress numerous times, has done dozens of media interviews about CFS and was selected by Redbook magazine as one of their 2001 “Mothers and Shakers” promoting progress in health.

Ms. McCleary lives in Charlotte, NC, is married to Kofi McCleary and has two teenage children, Lauren and Kyle Kenney. When 28 weeks pregnant with Kyle, Kim found out that she had an untreated Rh incompatibility that caused serious problems at Kyle’s birth and during his first few months of life. This is Ms. McCleary’s first year as a Board Director.

Richard C. Proctor Jr., MBA
Richard C. Proctor, Jr., Treasurer of the Board of Directors, is the Chief Executive Officer of Glenveigh Pharmaceuticals. Glenveigh is a biotech company focused on obstetrics and maternal-fetal medicine. The company initiated and is supporting a Phase 2 efficacy study of Digibind® for severe preeclampsia. Mr. Proctor joined Glenveigh in 2005 after 14 years with GlaxoSmithKline in Research Triangle Park, NC, most recently as the Director of US Business Development and Lifecycle Marketing. He was also involved with the Glaxo Wellcome charitable foundation. His background includes senior roles in project management, business development, marketing, and corporate finance. He attended Darlington School, Emory University (BBA), Wake Forest University (MBA), and has received many awards for his scholarship, leadership, and career success. This is his first year as a Board Director.

George F. Schreiner, M.D., Ph.D
Dr. George Schreiner joined San Francisco-based Raven Biotechnologies, Inc. in May 2006 as Chief Executive Officer. He is experienced in all phases of drug development, from discovery through clinical development to commercial launch. Prior to joining Raven, Dr. Schreiner was Chief Scientific Officer and Chief Medical Officer at Scios until its acquisition by Johnson & Johnson, whereupon he was named President. In that capacity, he oversaw research and development programs at Scios in cardiovascular disease, inflammation, and oncology. He served on the Pharmaceutical Research and Development Committee for Johnson & Johnson and chaired its Early Research and Development Committee. Dr. Schreiner received his M.D. from Harvard Medical School and his Ph.D. in immunology from Harvard University. He trained in internal medicine and nephrology at the Brigham and Women’s Hospital in Boston, held joint appointments on the faculties of the Department of Medicine and Pathology at Harvard Medical School and the Washington University School of Medicine, where he received tenure. Dr. Schreiner was one of the founding scientists at CV Therapeutics where he served as Vice President of Medical Science and Preclinical research. This is his first year as a Board Director.

Beth Schimel, Pharm. D.
Dr. Beth Schimel received a Bachelor of Science degree in Pharmacy from the University of Wisconsin in 1985. She then received a Doctor of Pharmacy degree in 1994 from University of Illinois-Chicago. She has practiced as a clinical pharmacist at a level-one trauma center in the ICU. She also was the Clinical Pharmacy Coordinator at a community hospital in the Milwaukee area. Dr Schimel moved to a position in the Pharmaceutical Industry in 1998. She has practiced as a Medical Science Liaison (MSL), a Training & Development director, and currently manages 11 MSLs across the 22 Western States. She and her husband live in New Berlin, WI (a suburb of Milwaukee). She and her husband enjoy travelling, especially to different wine regions in the US. She has served on the Board of Directors for Easter Seals of SE WI since 2007 and has recently been named to the board of the Preeclampsia Foundation.

John Warner
John Warner and his wife, Brenda, own and operate a family farm in eastern Iowa that has been in Mrs. Warner’s family for nearly 140 years. He is also employed at Kraft Foods in the maintenance department. Mr. Warner has been a member of the local Lions Club for 15 years, holding various positions within the club, including President. Mr. Warner has been an active volunteer with the Preeclampsia Foundation since January 2005 when his daughter, Shelly Bridgewater, 25, lost her life due to complications from severe preeclampsia/HELLP Syndrome one week after the birth of her daughter, his first grandchild. The Warners have another daughter, Kimberly. This is his first year as a Board Director.